The study of the effects of oral N/L-type calcium channel blocker cilnidipine on urinary excretions of albumin and podocyte in Japanese hypertensive patients.
Not Applicable
- Conditions
- hypertensive patients
- Registration Number
- JPRN-UMIN000009209
- Lead Sponsor
- Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
acute illness or malignant tumors drug allergy with pregnant or breast feeding, or candidates with such situations patients who are judged as inappropriate for inclusion by their physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method